- November 17, 2026
- Posted by: Josh Knoll
- Category: Prior Authorization

November 19th of this month is all set to be a significant date for medical providers and billers. Medicaid coverage for the state of New York is changing drastically. The new update in the regulation is set to change how practitioner-administered drugs are handled.
This update is only supposed to affect fee-for-service members and how they receive medication in an outpatient setting. In fact, practitioners and providers cannot simply administer specific medications without the necessary authorization.
From the outset, this might seem like a small update, but it certainly has far-reaching consequences. These updates can fundamentally change how prior authorization services and other billing support teams handle claims. Follow along to see what the new changes are and how they will affect billing as a whole.
What Are Practitioner-Administered Drugs?
Before understanding the changes, one needs to be clear about what practitioner-administered drugs (PAD) actually mean. PADs consist of medications that can only be administered by qualified professionals in a closed setting like a clinic or a facility.
These medications generally fall under the patient’s medical benefit. As a result, providers report these drugs using the relevant HCPCS code. However, prescribing these medications is quite different from other medications.
Unlike pharmacy-provided medications, PADs are directly supplied and administered by the practitioner. This turns medication administration into a service line, which in turn opens the door for specialized prior authorization services that excel at handling specialized billing challenges.
Related Reading: Manage The Humana and Athenahealth EPA Expansion and Prior Authorization Services
What Changes on November 19, 2026?
Fundamentally speaking, these new changes will affect how certain medications will be administered in the future. In short, it will introduce prior authorization requirements for selected PADs. The ecosystem is gradually moving away from manually entering details to something that is more structured.
The new process primarily uses medical claims and pharmacy data. As per the new regulations, payers will now check the member history against applicable clinical criteria. If the relevant information already exists, the system may generate approval, which in turn reduces additional work.
Then again, automatic approval is not guaranteed for every request. If the claim file contains gaps, then the claim might be subjected to further review. At the time of writing, these changes are only applicable to the state of New York. However, this could set off a chain reaction that affects other states as well.
Could Other States Introduce Similar Prior Authorization Requirements?
As per the current reports, these changes specifically apply to New York’s Medicaid Fee-for-Service programs. However, some buzz around the subject suggests that other states may soon follow suit.
One such name is South Carolina. The South Carolina Department of Health and Human Services (SCDHHS) announced authorization expansions on November 6, 2026. Like the New York updates, providers in South Carolina also need to obtain authorization before administering specific medications.
These developments suggest that more states are adopting their own authorization requirements, which means that prior authorization services need to be cautious of these changing currents. The right biller can help providers located across states to have a better understanding of state-specific requirements. As a result, the billing ecosystem stays up to date.
Which Drugs Are Included in the Initial Phase?
As per the latest reports, the first phase only covers a selected few drugs across several categories. However, providers must never assume details and must always refer to the latest state list. Here are the drugs that are included in the initial list:
- Botulinum toxin agents: Botox, Dysport, Myobloc, Xeomin, and Daxxify.
- Infliximab agents: Remicade, Renflexis, Avsola, Inflectra, and Zymfentra.
- Treatment-resistant depression: Spravato
- Spinal muscular atrophy: Spinraza
- Duchenne muscular dystrophy: Amondys 45, Exondys 51, Viltepso, Vyondys 53
The list is expected to be expanded in 2027 and beyond. Therefore, specializations such as DME, retina, cardiology, gastro, and pain management need to take note of these changes before proceeding. Or they could bring in expert prior authorization services that could handle the situation.
How PAD Authorization Connects with Medication Billing
One of the most important things about authorization is that it is only a single part of the reimbursement. Even if a claim has all the authorization, it does not mean that it will be paid in full. The final claim still has to meet all the billing requirements like correct codes, units and other similar details.
Tools such as the PAD Search Tool can help providers identify and verify covered drug combinations. What it does is list all the applicable HCPCS codes and the corresponding NDC information.
The recent changes have revamped how prior authorization services handle special medication claims. Due to these changes, billers tend to complete pricing and authorization checks together. Later on, the biller also needs to ensure that the administered dosage, product, and medication match the authorization. Otherwise, the claim becomes unpayable by the payer. This connects PAD changes to billing as well.
Common Errors That Can Affect PAD Claims
With the advent of newer regulations, the scope of error also gets updated. Here are some of the most common errors that can affect PAD claims:
- Checking the wrong Medicaid coverage type is one of the most common errors. Referencing the wrong coverage can create confusion, which can cascade into a financial escalation.
- Authorization requests can be another pain point. The billing team might notice the authorization requirement in retrospect. This is a sure-shot way of inviting problems.
- Incorrect usage of NDC categories is another common error that can be noticed rampantly.
These are some of the most common PAD claim errors that a provider needs to steer clear of. Thankfully, there are experienced prior authorization services that can help providers with this.
Related Reading: Embrace Technology to Resolve Prior Authorization Bottlenecks
How Outsourced Prior Authorization Services Support PAD Workflows
The new changes in the policy have created several points of connected responsibilities. The staff cannot simply verify coverage. In fact, they must also review drug requirements. Subsequently, the staff needs to collect clinical records and submit correct quantities. At the same time, they must monitor approval status and prepare accurate claims.
Therefore, it is safe to say that the responsibility has drastically increased. A billing team is not just there to submit claims and wait for payment. Billing and prior authorization services ensure that a claim is formulated correctly, and no crucial piece of information gets lost during information handoffs.
However, all of these things are only possible when the right biller is roped in. At SunKnowledge, we understand what billing and prior authorization support means for a medical practice. As a result, we offer one of the highest first-pass acceptance rates, at 97%. And the best part is that we offer our expertise and services at a flat fee of $7 per hour. Therefore, get on board with our years of excellence and manage the changing landscape of PAD claims the right way.
FAQ
Which Medicaid members are affected by this change?
This new update only applies to Medicaid Fee-for-Service members that are located in the state of New York. Managed Care members can still follow the authorization requirements of their health plan.
What does ePACES edit 00186 indicate?
Edit 00186 generally indicates that the required approval was not found in the claim. Therefore, the billing team needs to obtain approval before submitting the corrected claim.
How can providers check whether a drug needs authorization?
In order to check whether a drug needs authorization, the provider can check the clinical criteria of PAD and the subsequent authorization list.
Does prior authorization guarantee payment for a PAD claim?
Prior authorization is only a part of the reimbursement journey. Authorization does not automatically entail that a claim is payable. The final claim needs to fulfill the requirements set forth in order to guarantee payment.
